These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32280885)

  • 21. Mometasone furoate gel: a novel in-office treatment of recalcitrant postoperative chronic rhinosinusitis.
    Alava I; Isaacs S; Luong A; Citardi MJ; Fakhri S
    J Otolaryngol Head Neck Surg; 2012 Jun; 41(3):183-8. PubMed ID: 22762700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
    Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis.
    Liang Y; Zhang J; Zhao X; Wang M; Ding S; Wang Y; Chen Y; Liu J
    Curr Drug Deliv; 2021; 18(3):357-368. PubMed ID: 32940181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
    Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
    Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mometasone furoate sinus implant - a new targeted approach to treating recurrent nasal polyp disease.
    Shen J; Welch K; Kern R
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1163-1170. PubMed ID: 30457411
    [No Abstract]   [Full Text] [Related]  

  • 26. A thermoresponsive hydrogel system for long-acting corticosteroid delivery into the paranasal sinuses.
    Schilling AL; Kulahci Y; Moore J; Wang EW; Lee SE; Little SR
    J Control Release; 2021 Feb; 330():889-897. PubMed ID: 33157189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions.
    Masuda S; Deguchi S; Ogata F; Yoshitomi J; Otake H; Kanai K; Kawasaki N; Nagai N
    Int J Nanomedicine; 2023; 18():5685-5699. PubMed ID: 37841023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide loaded polymeric nanoparticles by non-aqueous nanoprecipitation.
    Haim Zada M; Rottenberg Y; Domb AJ
    J Colloid Interface Sci; 2022 Sep; 622():904-913. PubMed ID: 35561610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Intranasal Steroid Application Using Nasal Saline Irrigation and a Mucosal Atomization Device to Treat Chronic Rhinosinusitis.
    Waniewska-Leczycka M; Cieslik T; Kowalik K; Sierdzinski J; Zagor MP
    J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):311-321. PubMed ID: 33848434
    [No Abstract]   [Full Text] [Related]  

  • 31. Local Delivery of Mometasone Furoate from an Eluting Endotracheal Tube Reduces Airway Morbidity Following Long-Term Animal Intubation.
    Jahshan F; Abu Ammar A; Ertracht O; Eisenbach N; Daoud A; Sela E; Atar S; Zussman E; Fichtman B; Harel A; Gruber M
    ACS Appl Bio Mater; 2021 May; 4(5):4131-4139. PubMed ID: 35006827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mometasone implant for chronic rhinosinusitis.
    Wei CC; Kennedy DW
    Med Devices (Auckl); 2012; 5():75-80. PubMed ID: 23152712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
    Zhang N; Van Crombruggen K; Holtappels G; Lan F; Katotomichelakis M; Zhang L; Högger P; Bachert C
    PLoS One; 2014; 9(4):e93754. PubMed ID: 24710117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
    Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
    Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
    Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapidly Dissolving Microneedles for the Delivery of Steroid-Loaded Nanoparticles Intended for the Treatment of Inflammatory Skin Diseases.
    Dawud H; Abu Ammar A
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties.
    Bukhari A; Fatima Z; Atta M; Nazir A; Alshawwa SZ; Alotaibi HF; Iqbal M
    Dose Response; 2023; 21(1):15593258231152117. PubMed ID: 36743194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
    Bai X; Tang S; Butterworth S; Tirella A
    Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.